Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Glioma 3Brain Neoplasms 2Pituitary Neoplasms 1Non-Melanoma Skin Cancer (NMSC) 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms 1Neoplasm, Residual 1Keratosis, Actinic 1Central Nervous System Neoplasms 1

Interventions

Surgical Procedures, Operative 3Visual Field Tests 1Visual Acuity 1Surveys and Questionnaires 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Radiosurgery 1Magnetic Resonance Spectroscopy 1Human Growth Hormone 1Growth Hormone 1Dosage Forms 1Diffusion Tensor Imaging 1Critical Pathways 1Continuous Glucose Monitoring 1Clinical Laboratory Techniques 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Pituitary Neoplasms × Aminolevulinic Acid × Clear all
NCT04390802 2021-02-24

A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas

Massachusetts General Hospital

Unknown
40 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡